File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Cross-talk between Chk1 and Chk2 in double-mutant thymocytes

TitleCross-talk between Chk1 and Chk2 in double-mutant thymocytes
Authors
Keywordsp53
Apoptosis
bcl2
T cells
Cancer
Issue Date2007
Citation
Proceedings of the National Academy of Sciences of the United States of America, 2007, v. 104, n. 10, p. 3805-3810 How to Cite?
AbstractChk1 is a checkpoint kinase and an important regulator of mammalian cell division. Because null mutation of Chk1 in mice is embryonic lethal, we used the Cre-loxP system and the Lck promoter to generate conditional mutant mice in which Chk1 was deleted only in the T lineage. In the absence of Chk1, the transition of CD4-CD8- double-negative (DN) thymocytes to CD4+CD8+ double-positive (DP) cells was blocked due to an increase in apoptosis at the DN2 and DN3 stages. Strikingly, loss of Chk1 activated the checkpoint kinase Chk2 as well as the tumor suppressor p53 in these thymocytes. However, the developmental defects caused by Chk1 deletion were not rescued by p53 inactivation. Significantly, even though Chk1 deletion is highly lethal in proliferating tissues, we succeeded in using in vivo methods to generate Chk1/Chk2 double-knockout T cells. Analysis of these T cells revealed an interesting interaction between Chk1 and Chk2 functions that partially rescued the apoptosis of the double-mutant cells. Thus, Chk1 is both critical for the survival of proliferating cells and engages in cross-talk with the Chk2 checkpoint kinase pathway. These factors have implications for the targeting of Chk1 as an anticancer therapy. © 2007 by The National Academy of Sciences of the USA.
Persistent Identifierhttp://hdl.handle.net/10722/292604
ISSN
2021 Impact Factor: 12.779
2020 SCImago Journal Rankings: 5.011
PubMed Central ID
ISI Accession Number ID
Errata

 

DC FieldValueLanguage
dc.contributor.authorZaugg, Kathrin-
dc.contributor.authorSu, Yu Wen-
dc.contributor.authorReilly, Patrick T.-
dc.contributor.authorMoolani, Yasmin-
dc.contributor.authorCheung, Carol C.-
dc.contributor.authorHakem, Razquallah-
dc.contributor.authorHirao, Atsushi-
dc.contributor.authorElledge, Stephen J.-
dc.contributor.authorMak, Tak W.-
dc.date.accessioned2020-11-17T14:56:50Z-
dc.date.available2020-11-17T14:56:50Z-
dc.date.issued2007-
dc.identifier.citationProceedings of the National Academy of Sciences of the United States of America, 2007, v. 104, n. 10, p. 3805-3810-
dc.identifier.issn0027-8424-
dc.identifier.urihttp://hdl.handle.net/10722/292604-
dc.description.abstractChk1 is a checkpoint kinase and an important regulator of mammalian cell division. Because null mutation of Chk1 in mice is embryonic lethal, we used the Cre-loxP system and the Lck promoter to generate conditional mutant mice in which Chk1 was deleted only in the T lineage. In the absence of Chk1, the transition of CD4-CD8- double-negative (DN) thymocytes to CD4+CD8+ double-positive (DP) cells was blocked due to an increase in apoptosis at the DN2 and DN3 stages. Strikingly, loss of Chk1 activated the checkpoint kinase Chk2 as well as the tumor suppressor p53 in these thymocytes. However, the developmental defects caused by Chk1 deletion were not rescued by p53 inactivation. Significantly, even though Chk1 deletion is highly lethal in proliferating tissues, we succeeded in using in vivo methods to generate Chk1/Chk2 double-knockout T cells. Analysis of these T cells revealed an interesting interaction between Chk1 and Chk2 functions that partially rescued the apoptosis of the double-mutant cells. Thus, Chk1 is both critical for the survival of proliferating cells and engages in cross-talk with the Chk2 checkpoint kinase pathway. These factors have implications for the targeting of Chk1 as an anticancer therapy. © 2007 by The National Academy of Sciences of the USA.-
dc.languageeng-
dc.relation.ispartofProceedings of the National Academy of Sciences of the United States of America-
dc.subjectp53-
dc.subjectApoptosis-
dc.subjectbcl2-
dc.subjectT cells-
dc.subjectCancer-
dc.titleCross-talk between Chk1 and Chk2 in double-mutant thymocytes-
dc.typeArticle-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1073/pnas.0611584104-
dc.identifier.pmid17360434-
dc.identifier.pmcidPMC1820665-
dc.identifier.scopuseid_2-s2.0-34247183037-
dc.identifier.volume104-
dc.identifier.issue10-
dc.identifier.spage3805-
dc.identifier.epage3810-
dc.identifier.isiWOS:000244972400027-
dc.relation.erratumdoi:10.1073/pnas.0702353104-
dc.relation.erratumeid:eid_2-s2.0-34547514164-
dc.identifier.issnl0027-8424-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats